Natalia C. Llarena

ORCID: 0000-0002-9343-9789 · 16 papers in corpus
2024
·doi:10.1007/978-3-031-50662-8_11
2022
·doi:10.1007/978-3-030-47767-7_15
2022
·doi:10.1016/j.fertnstert.2022.08.842
observational 2022
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02406-2

PURPOSE: To compare morphokinetic parameters in embryos obtained from women with and without endometriosis. METHODS: We evaluated a total of 3471 embryos resulting from 434 oocyte retrievals performed at a single academic center. One thous…

case-report 2022
Case Reports in Obstetrics and Gynecology ·doi:10.1155/2022/3179656

Gynecologic emergencies may result from congenital uterine anomalies (CUAs) with outflow tract obstruction. Not limited to the "classic" presentation of an adolescent amenorrheic pain patient, such anomalies should be part of the differenti…

other 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01989-y

PURPOSE: To compare growth factor and cytokine profiles in the endometrial secretions of patients with and without endometriosis to determine whether a particular protein profile is predictive of the disease. METHODS: Patients undergoing l…

2020
·doi:10.1016/j.fertnstert.2020.08.607
review 2020
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2020.1738386

INTRODUCTION: Endometriosis is estimated to affect 10% of reproductive-aged women. The gold standard for treatment is surgery; however, surgery carries a significant morbidity and cost burden. There is an ongoing need for safe, effective me…

review 2019
Clinical medicine insights. Reproductive health ·doi:10.1177/1179558119873386

Infertility affects 30% to 50% of women with endometriosis. Women with endometriosis are at risk of decreased ovarian reserve, both because of the pathophysiology of the disease and iatrogenic injury resulting from surgical intervention. Fe…

2019
·doi:10.1016/j.fertnstert.2019.07.1298
2018
·doi:10.1016/j.fertnstert.2018.07.1077
meta-analysis 2018
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-018-1128-2

PURPOSE: To evaluate the available randomized controlled trials (RCTs) in the literature investigating the use of gonadotropin-releasing hormone agonist (GnRHa) co-treatment for ovarian preservation in women receiving chemotherapy. METHODS…

2018
·doi:10.1016/j.fertnstert.2018.07.1144
2017
·doi:10.1016/j.fertnstert.2017.07.1122
review 2017
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2017.04.004

Fibroid uterus can be managed medically, surgically, or through non-extirpative procedures, depending on the clinical situation. Myomectomy may be beneficial, especially to those desiring to preserve the uterus and/or fertility, with outcom…

review 2017
·doi:10.5301/jeppd.5000278

Endometriosis is commonly associated with dysmenorrhea, chronic pelvic pain, and infertility. When medical therapy fails, surgery is often recommended; unfortunately, endometriosis surgery can adversely impact fertility and ovarian reserve …